679-P: The Novel GIP, GLP-1, and Glucagon Triple Receptor Agonist LY3437943 Exhibits Robust Efficacy in Preclinical Models of Obesity and Diabetes

COSKUN, TAMER, MOYERS, JULIE S., ROELL, WILLIAM C. · Diabetes · 2021